Biolase (BIOLQ) 10-Q2008 Q1 Quarterly report

Filed: 9 May 08, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: advertising, APB, ARB, back, BL, bone, cancelled, Capallo, Chairman, choose, chosen, COBRA, corroborated, country, demonstration, EITF, eleven, EPS, essence, exit, fluctuation, foundation, Frederick, FSP, half, Harrison, hierarchy, identical, inlicense, issuance, Jake, level, Los, maximize, Mulder, noncontrolling, observable, Opinion, orderly, partner, Philip, principle, promote, prototyping, quoted, recharacterized, redeploying, regional, regulatory, remedial, repaid, research, Reseller, restructuring, Revenueson, Richard, salary, short, showed, shown, spend, St, strike, strong, subsidiary, successor, superseded, symposium, theezlasesystem, treatment, unobservable, Vendor, volume, withdrawezlase

Removed: achieve, adverse, allege, amend, answered, application, applied, applying, appoint, approving, assessed, attorney, award, BOW, carrier, Carter, challenge, claimed, Clemente, closed, conjunction, counsel, County, defendant, denying, description, dismissal, duty, entering, entirety, entity, expanded, expire, failing, fiduciary, forecasted, framework, fund, governance, growth, hearing, Honorable, implemented, individual, instrument, interpret, Judge, lack, LaserSmile, law, leaseback, leased, leave, margin, measuring, National, NTL, occur, offering, onezlase, Orange, ourself, paragraph, periodic, plaintiff, preceding, prejudice, preliminarily, pursuing, putative, reduced, reimbursement, relate, resolution, resolved, restate, ruled, San, settle, shareholder, standby, standing, state, Stipulation, suit, taxing, traceable, unspecified, violated, weighted, wrongdoing

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

BIOLQ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Jake St. Philip, Chief Executive Officer of BIOLASE Technology, Inc. (the “Company”), hereby certify that to the best of my knowledge:

	(1)		This quarterly report on Form 10-Q for the quarter ended March 31, 2008 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)		The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: May 9, 2008	/s/ JAKE ST. PHILIP
	Jake St. Philip
	Chief Executive Officer


*		This certificate accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.